Trial intelligence / Profile preview

Prednisolone and Aspirin in First ICSI Cycles

NCT03503227Phase 3Completed

Sponsor
Kasr Al Ainy Hospital
Start
Apr 2018
Primary completion
Oct 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of prednisolone in infertility, sponsored by Kasr Al Ainy Hospital. Primary endpoint: Clinical Pregnancy Rate per Cycle at 7 weeks. Started Apr 2018; status: completed.

02

Drugs

prednisolone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03503227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03503227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call